Is CRVO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CRVO. It does not provide personalized investment advice.

CRVO (CervoMed Inc. Common Stock) Stock Analysis - Financials

CervoMed Inc. Common Stock (CRVO) is a publicly traded Healthcare sector company. As of July 14, 2026, CRVO trades at $3.12 with a market cap of $30.65M and a P/E ratio of -1.04. CRVO moved -6.80% today. Year to date, CRVO is -61.01%; over the trailing twelve months it is -56.68%. Its 52-week range spans $1.80 to $16.94. Analyst consensus is strong buy with an average price target of $20.40. Rallies surfaces CRVO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CRVO's key financials?

CRVO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CRVO recently traded at $3.12. Market cap is $30.65M. P/E ratio is -1.04. Revenue is $4.01M.

CRVO Key Metrics

Key financial metrics for CRVO
Metric	Value
Price	$3.12
Market Cap	$30.65M
P/E Ratio	-1.04
EPS	$-2.98
Dividend Yield	0.00%
52-Week High	$16.94
52-Week Low	$1.80
Volume	849.03K
Avg Volume	0
Revenue (TTM)	$4.01M
Net Income	$-26.97M
Gross Margin	0.00%

CRVO Analyst Consensus

5 analysts cover CRVO: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.40.

Common questions about CRVO

What are CRVO's key financials?: CRVO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CRVO recently traded at $3.12. Market cap is $30.65M. P/E ratio is -1.04. Revenue is $4.01M.
Is CRVO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CRVO. It does not provide personalized investment advice.